世界の咽後膿瘍治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retropharyngeal Abscess Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4830
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、咽後膿瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、鎮痛剤、外科的ドレナージ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・咽後膿瘍治療の市場動向
・企業の競争状況、市場シェア
・咽後膿瘍治療の種類別市場規模と予測2016-2027（抗生物質、鎮痛剤、外科的ドレナージ、その他）
・咽後膿瘍治療の用途別市場規模と予測2016-2027（病院、クリニック、その他）
・咽後膿瘍治療の北米市場規模2016-2027（アメリカ、カナダ）
・咽後膿瘍治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・咽後膿瘍治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・咽後膿瘍治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・咽後膿瘍治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Sanofi、Novartis、Johnson & Johnson、GlaxoSmithKline、Merck、AstraZeneca、Mylan、Teva pharmaceutical）
・結論

A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection.

Market Analysis and Insights: Global Retropharyngeal Abscess Treatment Market
The global Retropharyngeal Abscess Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retropharyngeal Abscess Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retropharyngeal Abscess Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retropharyngeal Abscess Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retropharyngeal Abscess Treatment market.

Global Retropharyngeal Abscess Treatment Scope and Market Size
Retropharyngeal Abscess Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retropharyngeal Abscess Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibiotics
Pain Killers
Surgical Drainage
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Sanofi
Novartis
Johnson & Johnson
GlaxoSmithKline
Merck
AstraZeneca
Mylan
Teva pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retropharyngeal Abscess Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotics
1.2.3 Pain Killers
1.2.4 Surgical Drainage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Retropharyngeal Abscess Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retropharyngeal Abscess Treatment Market Perspective (2016-2027)
2.2 Retropharyngeal Abscess Treatment Growth Trends by Regions
2.2.1 Retropharyngeal Abscess Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retropharyngeal Abscess Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retropharyngeal Abscess Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retropharyngeal Abscess Treatment Industry Dynamic
2.3.1 Retropharyngeal Abscess Treatment Market Trends
2.3.2 Retropharyngeal Abscess Treatment Market Drivers
2.3.3 Retropharyngeal Abscess Treatment Market Challenges
2.3.4 Retropharyngeal Abscess Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retropharyngeal Abscess Treatment Players by Revenue
3.1.1 Global Top Retropharyngeal Abscess Treatment Players by Revenue (2016-2021)
3.1.2 Global Retropharyngeal Abscess Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retropharyngeal Abscess Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retropharyngeal Abscess Treatment Revenue
3.4 Global Retropharyngeal Abscess Treatment Market Concentration Ratio
3.4.1 Global Retropharyngeal Abscess Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retropharyngeal Abscess Treatment Revenue in 2020
3.5 Retropharyngeal Abscess Treatment Key Players Head office and Area Served
3.6 Key Players Retropharyngeal Abscess Treatment Product Solution and Service
3.7 Date of Enter into Retropharyngeal Abscess Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retropharyngeal Abscess Treatment Breakdown Data by Type
4.1 Global Retropharyngeal Abscess Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retropharyngeal Abscess Treatment Forecasted Market Size by Type (2022-2027)

5 Retropharyngeal Abscess Treatment Breakdown Data by Application
5.1 Global Retropharyngeal Abscess Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retropharyngeal Abscess Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retropharyngeal Abscess Treatment Market Size (2016-2027)
6.2 North America Retropharyngeal Abscess Treatment Market Size by Type
6.2.1 North America Retropharyngeal Abscess Treatment Market Size by Type (2016-2021)
6.2.2 North America Retropharyngeal Abscess Treatment Market Size by Type (2022-2027)
6.2.3 North America Retropharyngeal Abscess Treatment Market Size by Type (2016-2027)
6.3 North America Retropharyngeal Abscess Treatment Market Size by Application
6.3.1 North America Retropharyngeal Abscess Treatment Market Size by Application (2016-2021)
6.3.2 North America Retropharyngeal Abscess Treatment Market Size by Application (2022-2027)
6.3.3 North America Retropharyngeal Abscess Treatment Market Size by Application (2016-2027)
6.4 North America Retropharyngeal Abscess Treatment Market Size by Country
6.4.1 North America Retropharyngeal Abscess Treatment Market Size by Country (2016-2021)
6.4.2 North America Retropharyngeal Abscess Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retropharyngeal Abscess Treatment Market Size (2016-2027)
7.2 Europe Retropharyngeal Abscess Treatment Market Size by Type
7.2.1 Europe Retropharyngeal Abscess Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retropharyngeal Abscess Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retropharyngeal Abscess Treatment Market Size by Type (2016-2027)
7.3 Europe Retropharyngeal Abscess Treatment Market Size by Application
7.3.1 Europe Retropharyngeal Abscess Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retropharyngeal Abscess Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retropharyngeal Abscess Treatment Market Size by Application (2016-2027)
7.4 Europe Retropharyngeal Abscess Treatment Market Size by Country
7.4.1 Europe Retropharyngeal Abscess Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retropharyngeal Abscess Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retropharyngeal Abscess Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type
8.2.1 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application
8.3.1 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Region
8.4.1 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retropharyngeal Abscess Treatment Market Size (2016-2027)
9.2 Latin America Retropharyngeal Abscess Treatment Market Size by Type
9.2.1 Latin America Retropharyngeal Abscess Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retropharyngeal Abscess Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retropharyngeal Abscess Treatment Market Size by Type (2016-2027)
9.3 Latin America Retropharyngeal Abscess Treatment Market Size by Application
9.3.1 Latin America Retropharyngeal Abscess Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retropharyngeal Abscess Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retropharyngeal Abscess Treatment Market Size by Application (2016-2027)
9.4 Latin America Retropharyngeal Abscess Treatment Market Size by Country
9.4.1 Latin America Retropharyngeal Abscess Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retropharyngeal Abscess Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retropharyngeal Abscess Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type
10.2.1 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application
10.3.1 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Country
10.4.1 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Retropharyngeal Abscess Treatment Introduction
11.1.4 Pfizer Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Retropharyngeal Abscess Treatment Introduction
11.2.4 Sanofi Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Retropharyngeal Abscess Treatment Introduction
11.3.4 Novartis Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Retropharyngeal Abscess Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Retropharyngeal Abscess Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Retropharyngeal Abscess Treatment Introduction
11.6.4 Merck Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.6.5 Merck Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Retropharyngeal Abscess Treatment Introduction
11.7.4 AstraZeneca Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Retropharyngeal Abscess Treatment Introduction
11.8.4 Mylan Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Teva pharmaceutical
11.9.1 Teva pharmaceutical Company Details
11.9.2 Teva pharmaceutical Business Overview
11.9.3 Teva pharmaceutical Retropharyngeal Abscess Treatment Introduction
11.9.4 Teva pharmaceutical Revenue in Retropharyngeal Abscess Treatment Business (2016-2021)
11.9.5 Teva pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retropharyngeal Abscess Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotics
Table 3. Key Players of Pain Killers
Table 4. Key Players of Surgical Drainage
Table 5. Key Players of Others
Table 6. Global Retropharyngeal Abscess Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Retropharyngeal Abscess Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retropharyngeal Abscess Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Retropharyngeal Abscess Treatment Market Share by Regions (2016-2021)
Table 10. Global Retropharyngeal Abscess Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Retropharyngeal Abscess Treatment Market Share by Regions (2022-2027)
Table 12. Retropharyngeal Abscess Treatment Market Trends
Table 13. Retropharyngeal Abscess Treatment Market Drivers
Table 14. Retropharyngeal Abscess Treatment Market Challenges
Table 15. Retropharyngeal Abscess Treatment Market Restraints
Table 16. Global Retropharyngeal Abscess Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Retropharyngeal Abscess Treatment Market Share by Players (2016-2021)
Table 18. Global Top Retropharyngeal Abscess Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess Treatment as of 2020)
Table 19. Ranking of Global Top Retropharyngeal Abscess Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Retropharyngeal Abscess Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retropharyngeal Abscess Treatment Product Solution and Service
Table 23. Date of Enter into Retropharyngeal Abscess Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Retropharyngeal Abscess Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Retropharyngeal Abscess Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Retropharyngeal Abscess Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Retropharyngeal Abscess Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Retropharyngeal Abscess Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Retropharyngeal Abscess Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Retropharyngeal Abscess Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Retropharyngeal Abscess Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Retropharyngeal Abscess Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Retropharyngeal Abscess Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Retropharyngeal Abscess Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Retropharyngeal Abscess Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Retropharyngeal Abscess Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Retropharyngeal Abscess Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Retropharyngeal Abscess Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Retropharyngeal Abscess Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Retropharyngeal Abscess Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Retropharyngeal Abscess Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Retropharyngeal Abscess Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Retropharyngeal Abscess Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Retropharyngeal Abscess Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Retropharyngeal Abscess Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Retropharyngeal Abscess Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Retropharyngeal Abscess Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Retropharyngeal Abscess Treatment Product
Table 66. Pfizer Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Retropharyngeal Abscess Treatment Product
Table 71. Sanofi Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Retropharyngeal Abscess Treatment Product
Table 76. Novartis Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Retropharyngeal Abscess Treatment Product
Table 81. Johnson & Johnson Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 82. Johnson & Johnson Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Retropharyngeal Abscess Treatment Product
Table 86. GlaxoSmithKline Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Merck Company Details
Table 89. Merck Business Overview
Table 90. Merck Retropharyngeal Abscess Treatment Product
Table 91. Merck Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 92. Merck Recent Development
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Retropharyngeal Abscess Treatment Product
Table 96. AstraZeneca Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 97. AstraZeneca Recent Development
Table 98. Mylan Company Details
Table 99. Mylan Business Overview
Table 100. Mylan Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 101. Mylan Recent Development
Table 102. Teva pharmaceutical Company Details
Table 103. Teva pharmaceutical Business Overview
Table 104. Teva pharmaceutical Retropharyngeal Abscess Treatment Product
Table 105. Teva pharmaceutical Revenue in Retropharyngeal Abscess Treatment Business (2016-2021) & (US$ Million)
Table 106. Teva pharmaceutical Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retropharyngeal Abscess Treatment Market Share by Type: 2020 VS 2027
Figure 2. Antibiotics Features
Figure 3. Pain Killers Features
Figure 4. Surgical Drainage Features
Figure 5. Others Features
Figure 6. Global Retropharyngeal Abscess Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Retropharyngeal Abscess Treatment Report Years Considered
Figure 11. Global Retropharyngeal Abscess Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Retropharyngeal Abscess Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Retropharyngeal Abscess Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Retropharyngeal Abscess Treatment Market Share by Regions (2022-2027)
Figure 15. Global Retropharyngeal Abscess Treatment Market Share by Players in 2020
Figure 16. Global Top Retropharyngeal Abscess Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retropharyngeal Abscess Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Retropharyngeal Abscess Treatment Revenue in 2020
Figure 18. Global Retropharyngeal Abscess Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Retropharyngeal Abscess Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Retropharyngeal Abscess Treatment Market Share by Type (2016-2027)
Figure 22. North America Retropharyngeal Abscess Treatment Market Share by Application (2016-2027)
Figure 23. North America Retropharyngeal Abscess Treatment Market Share by Country (2016-2027)
Figure 24. United States Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retropharyngeal Abscess Treatment Market Share by Type (2016-2027)
Figure 28. Europe Retropharyngeal Abscess Treatment Market Share by Application (2016-2027)
Figure 29. Europe Retropharyngeal Abscess Treatment Market Share by Country (2016-2027)
Figure 30. Germany Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retropharyngeal Abscess Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Retropharyngeal Abscess Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Retropharyngeal Abscess Treatment Market Share by Region (2016-2027)
Figure 40. China Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retropharyngeal Abscess Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Retropharyngeal Abscess Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Retropharyngeal Abscess Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retropharyngeal Abscess Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Retropharyngeal Abscess Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Retropharyngeal Abscess Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Retropharyngeal Abscess Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 67. Teva pharmaceutical Revenue Growth Rate in Retropharyngeal Abscess Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の扁桃周囲膿瘍治療市場規模・現状・予測（2021年-2027年）

Global Peritonsillar Abscess Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5940 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、扁桃周囲膿瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ステロイド薬、鎮痛薬、経口吸引システム、往復手術装置、扁桃摘出装置）、用途別市場規模（病院、外来手術センター、専門クリニック、...

世界の腹腔内感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Intra-abdominal Infection Treatment Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4387 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、腹腔内感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クロラムフェニコール、ベータラクタム、キノロン、アミノグリコシド、その他）、用途別市場規模（腹腔内膿瘍、虫垂炎、憩室炎、下痢、食中毒、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の天然痘治療市場規模・現状・予測（2021年-2027年）

Global Smallpox Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6015 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、天然痘治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の中毒治療市場規模・現状・予測（2021年-2027年）

Global Poisoning Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4727 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、中毒治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（解毒剤、胃洗浄、浣腸、血液透析、その他）、用途別市場規模（病院、救急センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の扁桃周囲膿瘍治療市場規模・現状・予測（2021年-2027年） Peritonsillar abscess (PTA) also called quinsy. In this condition, the infection spreads behind tonsillitis. It occurs when there is pus collection and the infection spreads beyond the tonsils into the neck and chest. These swollen tissues cause airway blockage. Diagnosis can be done clinically, by …
世界の従来型＆疼痛代替治療市場規模・現状・予測（2021年-2027年） Conventional pain treatments included opiate and over-the-counter medications, whereas the most frequently endorsed lifetime complementary and alternative medicine pain treatmentsincluded stretching, physical exercise, physical therapy, heat therapy, and prayer. Conventional pain treatments included…
世界の痔瘻非外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Non-surgical methods include drugs as well as fibrin glue injections, adipose stem cell therapy, and collagen paste. Market Analysis and Insights: Global Anal Fistula …
世界の痔瘻外科治療市場規模・現状・予測（2021年-2027年） Anal fistula treatment involves use of both surgical and non-surgical approaches for effective removal of anal fistulae in patients. Surgical procedures include fistulotomy, bioprosthetic plugs, advancement flap procedures, seton techniques, and new techniques such as LIFT and FiLaC therapy. Market …
世界の非オピオイド疼痛治療市場規模・現状・予測（2021年-2027年） Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals. With growing concerns about the addictive nature of opioid painkillers, more and more companies are working to develop effective but not addictive therapies. The interest and demand for …